NASDAQ:XERS
Xeris Biopharma Holdings, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.xerispharma.comcrunchbase
xeris-pharmaceuticalslinkedin
xeris-pharmaceuticalsfounding date
Jan 01, 2005ipo date
Jun 21, 2018
Xeris Biopharma Holdings Inc is a biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology, neurology, and gastroenterology. The company has three commercially available products, Gvoke, ready-to-use liquid glucagon for the treatment of severe hypoglycemia, Keveyis, the first FDA-approved therapy for primary periodic par...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus